These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 37952981)

  • 1. Induced pluripotent stem cells-based disease modeling, drug screening, clinical trials, and reverse translational research for amyotrophic lateral sclerosis.
    Okano H; Morimoto S; Kato C; Nakahara J; Takahashi S
    J Neurochem; 2023 Dec; 167(5):603-614. PubMed ID: 37952981
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ropinirole, a New ALS Drug Candidate Developed Using iPSCs.
    Okano H; Yasuda D; Fujimori K; Morimoto S; Takahashi S
    Trends Pharmacol Sci; 2020 Feb; 41(2):99-109. PubMed ID: 31926602
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ropinirole hydrochloride remedy for amyotrophic lateral sclerosis - Protocol for a randomized, double-blind, placebo-controlled, single-center, and open-label continuation phase I/IIa clinical trial (ROPALS trial).
    Morimoto S; Takahashi S; Fukushima K; Saya H; Suzuki N; Aoki M; Okano H; Nakahara J
    Regen Ther; 2019 Dec; 11():143-166. PubMed ID: 31384636
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reverse engineering human neurodegenerative disease using pluripotent stem cell technology.
    Liu Y; Deng W
    Brain Res; 2016 May; 1638(Pt A):30-41. PubMed ID: 26423934
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Proteomic insights into extracellular vesicles in ALS for therapeutic potential of Ropinirole and biomarker discovery.
    Kato C; Ueda K; Morimoto S; Takahashi S; Nakamura S; Ozawa F; Ito D; Daté Y; Okada K; Kobayashi N; Nakahara J; Okano H
    Inflamm Regen; 2024 Jul; 44(1):32. PubMed ID: 38997748
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Maiden voyage: induced pluripotent stem cell-based drug screening for amyotrophic lateral sclerosis.
    Ito D; Morimoto S; Takahashi S; Okada K; Nakahara J; Okano H
    Brain; 2023 Jan; 146(1):13-19. PubMed ID: 36004509
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phase 1/2a clinical trial in ALS with ropinirole, a drug candidate identified by iPSC drug discovery.
    Morimoto S; Takahashi S; Ito D; Daté Y; Okada K; Kato C; Nakamura S; Ozawa F; Chyi CM; Nishiyama A; Suzuki N; Fujimori K; Kondo T; Takao M; Hirai M; Kabe Y; Suematsu M; Jinzaki M; Aoki M; Fujiki Y; Sato Y; Suzuki N; Nakahara J; ; Okano H
    Cell Stem Cell; 2023 Jun; 30(6):766-780.e9. PubMed ID: 37267913
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Induced Pluripotent Stem Cells and Their Applications in Amyotrophic Lateral Sclerosis.
    Du H; Huo Z; Chen Y; Zhao Z; Meng F; Wang X; Liu S; Zhang H; Zhou F; Liu J; Zhang L; Zhou S; Guan Y; Wang X
    Cells; 2023 Mar; 12(6):. PubMed ID: 36980310
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Induced pluripotent stem cell-based Drug Repurposing for Amyotrophic lateral sclerosis Medicine (iDReAM) study: protocol for a phase I dose escalation study of bosutinib for amyotrophic lateral sclerosis patients.
    Imamura K; Izumi Y; Banno H; Uozumi R; Morita S; Egawa N; Ayaki T; Nagai M; Nishiyama K; Watanabe Y; Hanajima R; Oki R; Fujita K; Takahashi N; Ikeda T; Shimizu A; Morinaga A; Hirohashi T; Fujii Y; Takahashi R; Inoue H
    BMJ Open; 2019 Dec; 9(12):e033131. PubMed ID: 31796494
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Ropinirole Hydrochloride, a Candidate Drug for ALS Treatment].
    Takahashi S; Morimoto S; Okano H
    Brain Nerve; 2019 Sep; 71(9):943-952. PubMed ID: 31506396
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Coactivation of GSK3β and IGF-1 Attenuates Amyotrophic Lateral Sclerosis Nerve Fiber Cytopathies in SOD1 Mutant Patient-Derived Motor Neurons.
    Ting HC; Yang HI; Harn HJ; Chiu IM; Su HL; Li X; Chen MF; Ho TJ; Liu CA; Tsai YJ; Chiou TW; Lin SZ; Chang CY
    Cells; 2021 Oct; 10(10):. PubMed ID: 34685754
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Advances in Patient-Specific Induced Pluripotent Stem Cells Shed Light on Drug Discovery for Amyotrophic Lateral Sclerosis.
    Lee JH; Liu JW; Lin SZ; Harn HJ; Chiou TW
    Cell Transplant; 2018 Sep; 27(9):1301-1312. PubMed ID: 30033758
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Ropinirole Hydrochloride for ALS].
    Takahashi S; Morimoto S; Fukushima K; Nakahara J; Okano H
    Brain Nerve; 2019 Nov; 71(11):1279-1288. PubMed ID: 31722314
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Generation of an Open-Access Patient-Derived iPSC Biobank for Amyotrophic Lateral Sclerosis Disease Modelling.
    Hedges EC; Cocks G; Shaw CE; Nishimura AL
    Genes (Basel); 2023 May; 14(5):. PubMed ID: 37239468
    [TBL] [Abstract][Full Text] [Related]  

  • 15. iPSC-based disease modeling and drug discovery in cardinal neurodegenerative disorders.
    Okano H; Morimoto S
    Cell Stem Cell; 2022 Feb; 29(2):189-208. PubMed ID: 35120619
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Edaravone activates the GDNF/RET neurotrophic signaling pathway and protects mRNA-induced motor neurons from iPS cells.
    Li Q; Feng Y; Xue Y; Zhan X; Fu Y; Gui G; Zhou W; Richard JP; Taga A; Li P; Mao X; Maragakis NJ; Ying M
    Mol Neurodegener; 2022 Jan; 17(1):8. PubMed ID: 35012575
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Induced pluripotent stem cell-derived motor neurons from amyotrophic lateral sclerosis (ALS) patients carrying different superoxide dismutase 1 mutations recapitulate pathological features of ALS.
    Liu WC; Liu N; Wang Y; Huang C; Li YF; Wang H; Li XG; Deng M
    Chin Med J (Engl); 2021 Oct; 134(20):2457-2464. PubMed ID: 34669638
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modeling hallmark pathology using motor neurons derived from the family and sporadic amyotrophic lateral sclerosis patient-specific iPS cells.
    Sun X; Song J; Huang H; Chen H; Qian K
    Stem Cell Res Ther; 2018 Nov; 9(1):315. PubMed ID: 30442180
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Motor neuron differentiation of iPSCs obtained from peripheral blood of a mutant TARDBP ALS patient.
    Bossolasco P; Sassone F; Gumina V; Peverelli S; Garzo M; Silani V
    Stem Cell Res; 2018 Jul; 30():61-68. PubMed ID: 29800782
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Safety and tolerability of bosutinib in patients with amyotrophic lateral sclerosis (iDReAM study): A multicentre, open-label, dose-escalation phase 1 trial.
    Imamura K; Izumi Y; Nagai M; Nishiyama K; Watanabe Y; Hanajima R; Egawa N; Ayaki T; Oki R; Fujita K; Uozumi R; Morinaga A; Hirohashi T; Fujii Y; Yamamoto T; Tatebe H; Tokuda T; Takahashi N; Morita S; Takahashi R; Inoue H
    EClinicalMedicine; 2022 Nov; 53():101707. PubMed ID: 36467452
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.